Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2026-2030

Market Size (2024)

USD 1105.80 Million

Market Size (2030)

USD 1773.46 Million

CAGR (2025-2030)

8.15%

Fastest Growing Segment

Dental Clinics

Largest Market

North America

Market Overview

Global Peri-implantitis Market was valued at USD 1105.80 Million in 2024 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 8.15% through 2030. Peri-implantitis is an inflammatory condition that affects the tissues surrounding dental implants. It is somewhat analogous to periodontitis, which is an inflammatory disease that affects the tissues surrounding natural teeth. Peri-implantitis specifically involves the inflammation and infection of the soft and hard tissues around a dental implant, which can lead to progressive loss of supporting bone and potentially result in implant failure if left untreated. Common signs and symptoms of peri-implantitis may include bleeding gums, swelling, redness, pus discharge, pain or discomfort around the implant, mobility or loosening of the implant, and, in advanced cases, visible gum recession and exposed implant threads. Several factors can increase the risk of developing peri-implantitis, including poor oral hygiene, smoking, a history of periodontal disease (gum disease), diabetes, certain medications, and a lack of regular dental check-ups and maintenance. Peri-implantitis is often categorized into stages, ranging from mild to severe, based on the extent of tissue and bone loss around the implant. Early detection and intervention are crucial for managing peri-implantitis effectively.

The global aging population is more likely to experience tooth loss and seek dental implant procedures. As the elderly population grows, the demand for peri-implantitis treatment is expected to increase. Ongoing advancements in dental implant materials, diagnostic tools, and treatment modalities have improved the effectiveness of peri-implantitis management. These technological innovations attract both patients and healthcare professionals. Increased awareness among patients about oral health and the risks associated with peri-implantitis has led to earlier diagnosis and treatment. Dental professionals are also focusing on patient education to promote preventive measures. Intense competition among dental implant manufacturers and providers is driving innovation in product development and treatment protocols. This competition can result in a wider array of options for peri-implantitis management. Positive patient outcomes and the preservation of dental implants through effective peri-implantitis treatment contribute to patient satisfaction and drive demand for such services.

Key Market Drivers

Rising Prevalence of Peri-implant Diseases

The rising prevalence of peri-implant diseases is a critical market driver that significantly influences the growth of the Global Peri-implantitis Market. Research indicates that peri-implantitis affects approximately 7% to 28% of patients with dental implants, while peri-implant mucositis is observed in 27% to 63% of cases. Although the World Health Organization (WHO) has not established specific guidelines on peri-implant disease incidence, its initiatives emphasize overall oral health management and the importance of preventive care in implant dentistry. Peri-implant diseases, including peri-implant mucositis and peri-implantitis, are becoming increasingly common due to the widespread adoption of dental implants. This growing burden has created a rising demand for preventive, diagnostic, and treatment solutions, fueling market expansion. The global surge in dental implant procedures has led to a proportional increase in peri-implant diseases. While dental implants are a preferred solution for tooth replacement due to their durability and functionality, they are also susceptible to infection and inflammation, which can lead to peri-implant diseases. The more implants placed, the higher the number of patients experiencing peri-implant conditions, thereby driving the demand for effective peri-implantitis treatment solutions.

Research indicates that a significant percentage of dental implant patients eventually develop peri-implant mucositis, which, if untreated, progresses to peri-implantitis. 20-50% of implant patients develop peri-implantitis. Over 80% experience some form of peri-implant inflammation. The long-term risk associated with implant failure due to peri-implant diseases has increased awareness among dental professionals and patients, prompting higher investments in peri-implantitis diagnostics and treatment solutions. The increased prevalence of peri-implant diseases has highlighted the need for early diagnosis and timely intervention. Advanced diagnostic tools (imaging systems, microbial testing). Minimally invasive treatments (lasers, antimicrobial agents). Regenerative solutions (bone grafts, bioactive materials). Companies are capitalizing on this demand by developing cutting-edge technologies that enhance peri-implantitis detection and treatment outcomes, thereby fueling market growth.

As the number of peri-implantitis cases increases, treatment costs have surged, making peri-implantitis management a high-value segment in the dental care industry.  Higher spending on peri-implantitis surgeries. Growing demand for antibiotic therapies. Increased use of specialized dental implants with antimicrobial coatings. The rising expenditure on peri-implantitis prevention and treatment has encouraged industry players to introduce cost-effective solutions, further expanding the market.

Rising Geriatric Population

The rising geriatric population is a significant driver fueling the expansion of the Global Peri-implantitis Market. The global aging population is expanding at an unprecedented rate, with individuals aged 60 and above expected to grow from 1.1 billion in 2023 to 1.4 billion by 2030 and reach 2.1 billion by 2050. This demographic shift is driving increased demand for age-specific healthcare solutions, particularly in dental care and implantology, as older adults seek long-term oral health interventions. As the world's population continues to age, the prevalence of tooth loss, dental implants, and peri-implant diseases is increasing, creating a sustained demand for peri-implantitis prevention, diagnosis, and treatment solutions. Aging is directly linked to tooth loss due to factors such as: Periodontal diseases (gum infections, bone loss). Dental caries (cavities) lead to tooth extraction. Osteoporosis weakening jawbone structure. Systemic diseases (diabetes, cardiovascular diseases) affect oral health.

As a result, older adults are among the largest consumer base for dental implants, leading to a proportional rise in peri-implant diseases such as peri-implant mucositis and peri-implantitis. The increasing number of geriatric patients undergoing dental implant procedures creates a strong demand for peri-implantitis treatment solutions, driving market growth. Global life expectancy is projected to increase by nearly five years by 2050. However, the growth in healthy life expectancy (HALE) may lag behind, indicating a potential rise in age-related health challenges, including chronic diseases and oral health complications. This trend underscores the need for advanced geriatric healthcare solutions, particularly in preventive and restorative dentistry. With life expectancy increasing globally, individuals are retaining their dental implants for longer periods, leading to a higher probability of developing peri-implant diseases over time. Higher demand for long-term implant maintenance programs. Expansion of geriatric-focused dental care services. Increased investment in preventive peri-implantitis solutions. As the elderly population grows, governments and healthcare providers are focusing on age-specific dental healthcare policies, further driving the peri-implantitis market.

Increasing Awareness and Education

Awareness campaigns and educational efforts can help individuals recognize the signs and symptoms of peri-implantitis at an early stage. When people are informed about the condition, they are more likely to seek professional dental care if they experience any concerning symptoms, such as bleeding gums, inflammation, or discomfort around dental implants. Education can promote preventive measures to reduce the risk of peri-implantitis. Patients who understand the importance of proper oral hygiene, regular dental check-ups, and implant maintenance are more likely to take steps to prevent peri-implantitis from developing in the first place.

Educated patients are more likely to follow their dentist's recommendations for post-implant care and maintenance. This can include regular dental cleanings, implant examinations, and adherence to oral hygiene practices that reduce the risk of peri-implantitis. Patients who are well-informed about the risks and benefits of dental implants are more likely to make informed decisions regarding implant placement and maintenance. They may also be more receptive to additional treatments if peri-implantitis is diagnosed. Education efforts can improve overall oral health literacy, making individuals more aware of the importance of oral health for their overall well-being. This can lead to a greater appreciation for dental implant procedures and their long-term implications. Some individuals may be hesitant to seek dental care or report peri-implantitis symptoms due to fear or stigma. Education can help reduce this stigma, encouraging individuals to seek timely treatment when needed. Awareness and education efforts are not limited to patients; they also target dental professionals. Dentists, oral surgeons, and dental hygienists who are well-informed about peri-implantitis are more likely to diagnose the condition accurately and provide appropriate treatment recommendations. Patients who are educated about peri-implantitis may become advocates for their own oral health and raise awareness among their peers and within their communities. This can lead to a positive ripple effect in terms of demand for peri-implantitis care. As awareness of peri-implantitis increases, the demand for related products and services, including diagnostic tools, treatment modalities, and maintenance products, is likely to grow. This can stimulate market expansion and innovation. This factor will accelerate the demand of the Global Peri-implantitis Market.

Peri-implantitis Market
Download Free Sample Report

Key Market Challenges

Cost of Treatment

Peri-implantitis treatment can be costly, particularly in cases where surgical interventions, such as open flap debridement, bone grafting, or implant removal and replacement, are required. The expenses associated with these procedures, including professional fees, facility charges, and post-operative care, can add up quickly. Dental insurance plans often do not provide comprehensive coverage for peri-implantitis treatment. This lack of coverage can place a significant financial burden on patients, making treatment less accessible. Many peri-implantitis treatment expenses are out-of-pocket costs for patients. This includes the cost of diagnostic tests, consultations with specialists, surgical procedures, medications, and follow-up care. Peri-implantitis treatment may require multiple treatment sessions and follow-up appointments, which can further increase the overall cost for patients. The cost of peri-implantitis treatment can vary widely depending on the severity of the condition, the complexity of the procedures required, the geographic location of the dental practice, and the expertise of the treating professionals. Patients with limited financial resources may find it challenging to afford the upfront costs associated with peri-implantitis treatment. This can lead to delays in seeking care or a reluctance to pursue treatment altogether. High treatment costs can have a significant impact on the quality of life of patients with peri-implantitis. They may have to make difficult choices between their oral health and other essential expenses. Patients in underserved or remote areas may have limited access to specialized dental professionals with expertise in peri-implantitis treatment. Traveling long distances to seek care can add to the overall cost.

Implant Longevity

Peri-implantitis is characterized by bacterial infection and inflammation around the implant site. If not effectively treated, this can lead to bone loss and implant instability, ultimately resulting in implant failure. Peri-implantitis can lead to progressive bone loss around the implant, which can weaken the implant's anchorage. Over time, extensive bone resorption may make it impossible to maintain implant stability. Successful osseointegration, the integration of the implant with the surrounding bone, is essential for implant stability and longevity. Peri-implantitis can disrupt osseointegration and compromise the implant's long-term performance. As peri-implantitis progresses, patients may experience implant mobility, which is a clear sign of implant instability. Mobile implants are at high risk of failure and may need to be removed. In severe cases of peri-implantitis, implant removal may be necessary to prevent further complications. This not only results in the loss of the implant but also necessitates additional costs for implant replacement. Even after successful peri-implantitis treatment, patients remain at risk of recurrent infections. This can lead to a cycle of treatment and reinfection, compromising implant longevity. Patients with chronic diseases such as diabetes or autoimmune disorders may have compromised immune systems, making them more susceptible to peri-implantitis and implant complications. The long-term success of dental implants depends on patients' commitment to oral hygiene and maintenance, including regular dental check-ups. Non-compliance with post-implant care recommendations can negatively impact implant longevity.

Key Market Trends

Treatment Modalities

Surgical treatment modalities, such as open flap debridement, bone grafting, and guided tissue regeneration, continue to be prominent in peri-implantitis management. Advancements in surgical techniques and materials enhance their effectiveness. Laser technology, including diode lasers and erbium lasers, has gained popularity for the treatment of peri-implantitis. Lasers can effectively remove infected tissue, disinfect implant surfaces, and promote tissue regeneration. Various antimicrobial agents, including topical antibiotics and antiseptics, are used in the treatment of peri-implantitis to control bacterial infections. Research is ongoing to develop more targeted and effective antimicrobial treatments. Implantoplasty involves the mechanical smoothing of rough implant surfaces to remove biofilm and encourage re-osseointegration. This minimally invasive approach is gaining attention as a potential treatment option. Non-surgical modalities, such as mechanical debridement and air abrasive therapy, are considered for less severe cases of peri-implantitis. These methods aim to remove biofilm and calculus without the need for surgical intervention. Personalized treatment plans based on the specific needs of each patient are becoming more common. This includes considering factors like the extent of tissue loss, bone quality, and patient health status. Biomaterials, growth factors, and tissue engineering scaffolds are being explored to enhance tissue regeneration around dental implants affected by peri-implantitis. Telehealth platforms and teledentistry services are being utilized for remote consultations, monitoring, and follow-up care, making peri-implantitis treatment more accessible to patients. Research into smart implants with integrated sensors and monitoring capabilities is ongoing. These implants may provide real-time data on the health of the implant and surrounding tissues, aiding in treatment decisions.

Segmental Insights

End-User Insights

In 2024, Based on category of End User, Dental clinics segment emerges as the fastest growing segment in the Global Peri-implantitis Market during the forecast period and is predicted to continue expanding over the coming years.  Peri-implantitis, which is an inflammatory condition affecting dental implants, often requires specialized and complex treatment. Hospitals, particularly those with dental departments or oral surgery units, are well-equipped to provide a wide range of dental services, including surgical procedures, which may be necessary for the treatment of peri-implantitis. Hospitals typically have a pool of specialized dental professionals, including oral surgeons, periodontists, and prosthodontists, who are trained to diagnose and treat peri-implantitis effectively. These specialists can provide comprehensive care for patients with peri-implantitis, from diagnosis to treatment and follow-up. In some instances, peri-implantitis can lead to acute complications that require emergency care. Hospitals are equipped to handle emergency cases, providing timely treatment to prevent further complications. Hospitals can offer both inpatient and outpatient services, making them suitable for managing a wide range of peri-implantitis cases. Severe cases may require hospitalization, while less severe cases can be managed on an outpatient basis.

Peri-implantitis Market
Download Free Sample Report

Regional Insights

The North America region emerges as the largest market in the Global Peri-implantitis Market in 2024. North America, particularly the United States and Canada, had a high prevalence of dental implant procedures. The region's well-developed healthcare infrastructure and a relatively high standard of living contributed to the popularity of dental implants as a restorative dental solution. The aging population in North America was a significant driver of dental implant procedures. Older individuals are more likely to experience tooth loss and seek dental implants as a replacement option. North America is home to many leading dental implant manufacturers and research institutions. Ongoing technological advancements in dental implant materials and techniques, including those aimed at preventing and treating peri-implantitis, often originate in this region. In some parts of North America, dental insurance coverage is relatively common, making it more affordable for patients to undergo dental implant procedures and related treatments, including those for peri-implantitis.

Recent Developments

  • In February 2025, ZimVie Inc. announced the publication of a scientific study in the Journal of Biomedical Materials Research, highlighting the benefits of its dental implant surface technology. The study evaluates the dual acid-etched coronal surface technology of ZimVie's T3® PRO and TSX® implants, comparing their performance against other leading implant brands in terms of osseointegration and clinical efficacy.
  • In November 2024, Integral Dental has introduced OraclePI, its first commercial product and the only early diagnostic test for peri-implantitis, according to the company. OraclePI provides a comprehensive disease diagnosis and delivers personalized treatment recommendations based on patient-specific data, aiming to enhance early intervention and clinical outcomes in implant dentistry.
  • In March 2024, YAG dental lasers are advanced surgical instruments designed to achieve precise clinical outcomes in periodontal and implant therapies. They play a critical role in LANAP (Laser-Assisted New Attachment Procedure) for treating periodontitis and LAPIP (Laser-Assisted Peri-Implantitis Procedure) for managing peri-implantitis, facilitating minimally invasive tissue regeneration and infection control.
  • In February 2024, ZimVie Inc., a global leader in dental and spine technologies, announced the launch of its TSX® Implant in Japan. As ZimVie's largest dental implant market in the APAC region and its fifth largest globally, Japan represents a key strategic growth area for the company. The introduction of TSX® positions ZimVie to compete directly with top-tier market leaders, strengthening its presence in the premium dental implant segment.

Key Market Players

  • Pfizer Inc.
  • Cadila Pharmaceuticals Ltd.
  • R.N. Laboratories Pvt. Ltd.
  • Basic Pharma Life Science Pvt. Ltd
  • Prachi Pharmaceuticals Private Limited
  • Geistlich Pharma Inc.
  • Healthy Life Pharma

By Type

By End User

By Region

  • Non-Surgical
  • Surgical
  • Dental Clinics
  • Hospitals
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

 Report Scope:

In this report, the Global Peri-implantitis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  •     Peri-implantitis Market, By Type:

o   Non-Surgical

o   Surgical

  •     Peri-implantitis Market, By End-User:

o   Dental Clinics

o   Hospitals

  • Global Peri-implantitis Market, By region:

o   North America

§  United States

§  Canada

§  Mexico

o   Asia-Pacific

§  China

§  India

§  South Korea

§  Australia

§  Japan

o   Europe

§  Germany

§  France

§  United Kingdom

§  Spain

§  Italy

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Peri-implantitis Market.

Available Customizations:

Global Peri-implantitis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Peri-implantitis Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Peri-implantitis Market Outlook

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Type (Non-Surgical, Surgical)

5.2.2.    By End-User (Dental Clinics, Hospitals)

5.2.3.    By Region

5.2.4.    By Company (2024)

5.3.  Market Map

6.    North America Peri-implantitis Market Outlook

6.1.  Market Size & Forecast       

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Type

6.2.2.    By End User

6.2.3.    By Country

6.3.  North America: Country Analysis

6.3.1.    United States Peri-implantitis Market Outlook

6.3.1.1.        Market Size & Forecast

6.3.1.1.1.           By Value

6.3.1.2.        Market Share & Forecast

6.3.1.2.1.           By Type

6.3.1.2.2.           By End User

6.3.2.    Canada Peri-implantitis Market Outlook

6.3.2.1.        Market Size & Forecast

6.3.2.1.1.           By Value

6.3.2.2.        Market Share & Forecast

6.3.2.2.1.           By Type

6.3.2.2.2.           By End User

6.3.3.    Mexico Peri-implantitis Market Outlook

6.3.3.1.        Market Size & Forecast

6.3.3.1.1.           By Value

6.3.3.2.        Market Share & Forecast

6.3.3.2.1.           By Type

6.3.3.2.2.           By End User

7.    Europe Peri-implantitis Market Outlook

7.1.  Market Size & Forecast       

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Type

7.2.2.    By End User

7.2.3.    By Country

7.3.  Europe: Country Analysis

7.3.1.    Germany Peri-implantitis Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.           By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.           By Type

7.3.1.2.2.           By End User

7.3.2.    United Kingdom Peri-implantitis Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.           By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.           By Type

7.3.2.2.2.           By End User

7.3.3.    Italy Peri-implantitis Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.           By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.           By Type

7.3.3.2.2.           By End User

7.3.4.    France Peri-implantitis Market Outlook

7.3.4.1.        Market Size & Forecast

7.3.4.1.1.           By Value

7.3.4.2.        Market Share & Forecast

7.3.4.2.1.           By Type

7.3.4.2.2.           By End User

7.3.5.    Spain Peri-implantitis Market Outlook

7.3.5.1.        Market Size & Forecast

7.3.5.1.1.           By Value

7.3.5.2.        Market Share & Forecast

7.3.5.2.1.           By Type

7.3.5.2.2.           By End User

8.    Asia-Pacific Peri-implantitis Market Outlook

8.1.  Market Size & Forecast       

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    By Type

8.2.2.    By End User

8.2.3.    By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.    China Peri-implantitis Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.           By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.           By Type

8.3.1.2.2.           By End User

8.3.2.    India Peri-implantitis Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.           By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.           By Type

8.3.2.2.2.           By End User

8.3.3.    Japan Peri-implantitis Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.           By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.           By Type

8.3.3.2.2.           By End User

8.3.4.    South Korea Peri-implantitis Market Outlook

8.3.4.1.        Market Size & Forecast

8.3.4.1.1.           By Value

8.3.4.2.        Market Share & Forecast

8.3.4.2.1.           By Type

8.3.4.2.2.           By End User

8.3.5.    Australia Peri-implantitis Market Outlook

8.3.5.1.        Market Size & Forecast

8.3.5.1.1.           By Value

8.3.5.2.        Market Share & Forecast

8.3.5.2.1.           By Type

8.3.5.2.2.           By End User

9.    South America Peri-implantitis Market Outlook

9.1.  Market Size & Forecast       

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    By Type

9.2.2.    By End User

9.2.3.    By Country

9.3.  South America: Country Analysis

9.3.1.    Brazil Peri-implantitis Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.           By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.           By Type

9.3.1.2.2.           By End User

9.3.2.    Argentina Peri-implantitis Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.           By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.           By Type

9.3.2.2.2.           By End User

9.3.3.    Colombia Peri-implantitis Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.           By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.           By Type

9.3.3.2.2.           By End User

10. Middle East and Africa Peri-implantitis Market Outlook

10.1.             Market Size & Forecast        

10.1.1. By Value

10.2.             Market Share & Forecast

10.2.1. By Type

10.2.2. By End User

10.2.3. By Country

10.3.             MEA: Country Analysis

10.3.1. South Africa Peri-implantitis Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         By Type

10.3.1.2.2.         By End User

10.3.2. Saudi Arabia Peri-implantitis Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         By Type

10.3.2.2.2.         By End User

10.3.3. UAE Peri-implantitis Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         By Type

10.3.3.2.2.         By End User

11. Market Dynamics

11.1.   Drivers

11.2.   Challenges

12. Market Trends & Developments

12.1.   Recent Developments

12.2.   Product Launches

12.3.   Mergers & Acquisitions

13. Global Peri-implantitis Market: SWOT Analysis

14. Competitive Landscape

14.1.   Pfizer Inc.

14.1.1.       Business Overview

14.1.2.       Product & Service Offerings

14.1.3.       Recent Developments

14.1.4.       Financials (If Listed)

14.1.5.       Key Personnel

14.1.6.       SWOT Analysis

14.2.   Cadila Pharmaceuticals Ltd.

14.3.   R.N. Laboratories Pvt. Ltd.

14.4.   Basic Pharma Life Science Pvt. Ltd

14.5.   Prachi Pharmaceuticals Private Limited

14.6.   Geistlich Pharma Inc.

14.7.   Healthy Life Pharma.

15. Strategic Recommendations

16. About Us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The market size of the Peri-implantitis Market was estimated to be USD 1105.80 Million in 2024.

Pfizer Inc., Cadila Pharmaceuticals Ltd., R.N. Laboratories Pvt. Ltd., Basic Pharma Life Science Pvt. Ltd, Prachi Pharmaceuticals Private Limited ere the top players operating in the Global Peri-implantitis Market in 2024.

Cost of Treatment and Implant Longevity are the challenges faced by the Global Peri-implantitis Market in the upcoming years.

Rising Prevalence of Peri-implant Diseases and Rising Geriatric Population are the major drivers which drives the growth of the Global Peri-implantitis Market.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.